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Reply
We read the comments from Takagi et al with great interest.
Their letter outlines an interesting and thought-provoking meta-
analysis demonstrating the protective benefits of preoperative statin
therapy in patients with noncoronary vascular disease. In addition to
the studies cited in our manuscript, this letter cites several other
important sources which add credence to our hypothesis regarding
the influence of statin-class drugs on operative outcomes and resource
utilization after aneurysm surgery. Takagi et al should be commended
for this analysis, and we would urge the authors to consider a robust
publication of the methodology and data.
There exists a considerable body of literature demonstrating a
protective benefit attributable to statin therapy in patients with both
central and peripheral vascular disease. The data are so compelling,
that one might argue that there are ethical considerations to random-
ized trials as suggested by Takagi and colleagues. Statistical analyses
such as this, and comparative effectiveness research should be used to
develop evidence-based guidelines regarding the appropriate risk op-
timization of patients with vascular disease.
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